This is a bit strange...trade was done at 3 cents per share. Whilst it appears to be purely a transfer between accounts, its an odd price.Anyway, hopefully there is more to it...we need some change here to get this moving.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%